Catalyst Pharmaceuticals (NASDAQ:CPRX) Coverage Initiated by Analysts at Bank of America themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Bank of America assumed coverage on shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) in a research note published on Thursday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $23.00 price objective on the biopharmaceutical company’s stock. CPRX has been the topic of several other research reports. Cantor Fitzgerald boosted their […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) – Zacks Research lowered their Q3 2023 earnings estimates for Catalyst Pharmaceuticals in a report issued on Wednesday, August 23rd. Zacks Research analyst A. Chakraborty now forecasts that the biopharmaceutical company will earn ($0.21) per share for the quarter, down from their previous estimate of $0.27. The consensus […]
Catalyst Pharmaceuticals (CPRX) Overweight Rating Reaffirmed at Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Brokerages Set Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Price Target at $22 90 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.